scholarly journals Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response

2018 ◽  
Vol 7 (8) ◽  
pp. 3642-3651 ◽  
Author(s):  
Thomas I. Banks ◽  
Rie von Eyben ◽  
Dimitre Hristov ◽  
Elizabeth A. Kidd
Keyword(s):  
Pilot Study ◽  
Fdg Pet ◽  
Concurrent Chemoradiotherapy ◽  
Locally Advanced ◽  
Dynamic Contrast Enhanced ◽  
Contrast Enhanced Ct ◽  
Advanced Cervical Carcinoma ◽  
Contrast Enhanced ◽  
Enhanced Ct ◽  
Dynamic Contrast Enhanced Ct

scholarly journals Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT

2017 ◽  
Vol 56 (11) ◽  
pp. 1591-1596 ◽  
Author(s):  
Aniek J. G. Even ◽  
Bart Reymen ◽  
Matthew D. La Fontaine ◽  
Marco Das ◽  
Arthur Jochems ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Fdg Pet ◽  
Tumor Hypoxia ◽  
Small Cell ◽  
Small Cell Lung ◽  
Dynamic Contrast Enhanced ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct ◽  
Dynamic Contrast Enhanced Ct

scholarly journals Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PET

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
K. A. Miles ◽  
R. E. Williams ◽  
D. Yu ◽  
M. R. Griffiths
Keyword(s):  
Fdg Pet ◽  
Pearson Correlation ◽  
Hepatic Metastases ◽  
Correlation Coefficients ◽  
Metabolic Phenotype ◽  
Dynamic Contrast Enhanced ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct ◽  
Dynamic Contrast Enhanced Ct

Purpose. To assess whether the differences in vascular-metabolic relationships between lymphoma masses and colorectal liver metastases predicted from previous histopathological studies can be demonstrated by dynamic contrast-enhanced CT (DCE-CT) combined with fluorodeoxyglucose positron emission tomography (FDG-PET). Methods. DCE-CT and FDG-PET studies were drawn from an imaging archive for patients with either lymphoma masses (n=11) or hepatic metastases from colorectal cancer (CRM: n=12). Tumour vascularity was assessed using DCE-CT measurements of perfusion. Tumour glucose metabolism was expressed as the mean FDG Standardised Uptake Value (SUVFDG). The relationship between metabolism and vascularity in each group was assessed from SUVFDG /perfusion ratios and Pearson correlation coefficients. Results. An SUVFDG threshold of 3.0 was used to designate lymphoma masses as active (AL, n=6) or inactive lymphoma (IL, n=5). Tumour perfusion was significantly higher in AL (0.65 mL/min/mL) than CRM (0.37 mL/min/mL: P=.031) despite similar SUVFDG (5.05 and 5.33, resp.). AL demonstrated higher perfusion values than IL (0.24 mL/min/mL: P=.006). SUVFDG/perfusion was significantly higher in CRM (15.3 min) than IL (4.2 min, P<.01). There was no correlation between SUVFDG and perfusion for any patient group.

Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study

2018 ◽  
Vol 29 (2) ◽  
pp. 682-688 ◽  
Author(s):  
Eyjolfur Gudmundsson ◽  
Zacariah Labby ◽  
Christopher M. Straus ◽  
William F. Sensakovic ◽  
Feng Li ◽  
...  
Keyword(s):  
Pilot Study ◽  
Malignant Pleural Mesothelioma ◽  
Tumour Response ◽  
Pleural Mesothelioma ◽  
Dynamic Contrast Enhanced ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct ◽  
Dynamic Contrast Enhanced Ct
Sign in / Sign up

Export Citation Format

Share Document